... suggestive ofheadandneck cancer. 3.2 DIAGNOSIS AND STAGING Diagnosis and staging ofheadandneck malignancy will normally include clinical examination byanexperiencedclinician,breopticendoscopy,neneedleaspiration(FNA)/corebiopsy of any ... Noevidencewasidentiedtosupporttheuse of chemotherapyaloneasacurativetreatmentfor squamous carcinoma ofheadand neck. In patients with headandneckcancer the administration of chemotherapy in combination with ... MANAGEMENT OFHEADANDNECK CANCER 335 Overview of treatment of the primary tumour and neck Thissectionaddressestherstlinetreatment ofheadandneck cancer. Management of recurrenttumour...
... Guide to NECK DISSECTIONCLASSIFICATION AND TNMSTAGING OFHEAD AND NECK CANCER Committee for HeadandNeck Surgery and OncologyAmerican Academy of Otolaryngology– Head andNeck Surgery Neck Dissection ... guide to neck dissection classification and TNM staging ofhead and neck cancer. — 3rd ed. / Committee for HeadandNeck Surgery and Oncol-ogy, American Academy of Otolaryngology HeadandNeck Surgery ... of: Pocket guide to neck dissection classification and TNMstaging ofheadandneckcancer / Committee for Neck DissectionClassification, American HeadandNeck Society [and] Committee for Head and...
... criteria.BFine needle aspiration cytology should be used in the investigation ofheadandneck masses. DThe risk of having headandneckcancer can be reduced by: not smoking or chewing tobacco ... limiting alcohol consumption, in line with government guidelines increasing the intake of fruit and vegetables (specifically tomatoes), olive oil and fish oils reducing the intake of ... metastatic disease in patients with headandneckcancer should include: number of involved nodes level of involved nodes extracapsular spread of tumourC2DIAGNOSIS AND STAGING (cont)CT...
... research and clinical purpose in order to determine the global functional outcome of speech and voice after the treatment ofheadandneck cancer. Itallows quantifying the intelligibility also in ... therapy of malignant diseases of the head and neck, communication skills are of special interest. Untilnow, no objective method with low effort and costs existedto determine speech and voice ... validationset (the training and validation corpora were the same as in [16]).This ASR system is integrated into the “Program for theEvaluation and Analysis of all Kinds of Speech disorders”(PEAKS)...
... of advanced-stage headandneck cancer. HeadNeck 1997, 19:500-505.28. Mazer TM, Robbins KT, McMurtrey MJ, Byers RM: Resection of pulmonarymetastases from squamous carcinoma of the headand neck. Am J ... publicationFile.pdf/KID2008.pdf].2. Mashberg A, Boffetta P, Winkelman R, Garfinkel L: Tobacco smoking,alcohol drinking, andcancerof the oral cavity and oropharynx amongU.S. veterans. Cancer 1993, 72:1369-1375.3. ... tract cancer [28]. Finley et al reported ontheir evaluation of surgical resection of pulmonarymetastases ofheadandneckcancer that a resection of asolitary pulmonary metastasis resulted in...
... an H score of morethan 1.5 and were thus defined as having a high expression of ERCC1. As can be seen in Table 1 a summary of result of the ERCC1 immunostaining of the cancer cells and itscorrelation ... predicts cisplatin-based chemotherapy resistance and poor outcome in unresectablesquamous cell carcinoma ofheadandneckin a betel-chewing area.Journal of Translational Medicine 2011 9:31.Chiu ... ≤2ontheEasternCooperativeOncologyGroup(ECOG)scale,adequatebonemarrow,hepatic and renal function (creatinine clearance >60 ml/min), and a compute d tomography or magnetic reson anceimage scan of the headandneck region within t hreeweeks prior to the initiation of...
... an H score of morethan 1.5 and were thus defined as having a high expression of ERCC1. As can be seen in Table 1 a summary of result of the ERCC1 immunostaining of the cancer cells and itscorrelation ... predicts cisplatin-based chemotherapy resistance and poor outcome in unresectablesquamous cell carcinoma ofheadandneckin a betel-chewing area.Journal of Translational Medicine 2011 9:31.Chiu ... ≤2ontheEasternCooperativeOncologyGroup(ECOG)scale,adequatebonemarrow,hepatic and renal function (creatinine clearance >60 ml/min), and a compute d tomography or magnetic reson anceimage scan of the headandneck region within t hreeweeks prior to the initiation of...
... E:Apoptotic and inflammation markers in oral mucositis inheadand neck cancer patients receiving radiotherapy: preliminary report. Support Care Cancer 2008, 16:1025-1033.20. Dinarello CA: Biology of interleukin ... pilot study of longitudinal serum cytokine and angiogenesisfactor levels as markers of therapeutic response and survival in patientswith headandneck squamous cell carcinoma. HeadNeck 2005,27:771-784.17. ... Expression of proinflammatory and proangiogenic cytokines in patients with headandneck cancer. Clin Cancer Res 1999, 5:1369-1379.9. Kanazawa T, Nishino H, Hasegawa M, Ohta Y, Iino Y, Ichimura...
... areasmight be useful in assigning dose intensification duringIMRT. Of course, the medical significance of includingthese additional data in the original treatment plan onfinal patient outcome ... PET-CT-based intensity-modulated radiotherapytreatment planning ofheadandneck cancer. Int J Radiat Oncol Biol Phys2007, 69:286-293.26. Schinagl DA, Vogel WV, Hoffmann AL, van Dalen JA, Oyen WJ, Kaanders ... J, Ringash J, Yu E, Hendler A,Waldron J: Intraobserver and interobserver variability in GTV delineationon FDG-PET-CT images ofheadandneck cancers. Int J Radiat Oncol BiolPhys 2007, 68:763-770.30....
... radiathion therapy in headandneck cancers: an update. HeadandNeck 2007, 29:387-400.3. Popovtzer A, Eisbruch A: Advances in radiation therapy ofheadand neck cancer. Expert Rev Anticancer Ther ... extent of tumour shown by imaging, including allinvolved (positive) lymph nodes. MRI, andin few casesFDG-PET, were used in the delineation of GTV. On thebasis of the primary t umour size and involved ... the usage of rather small CTV toPTV margins. Moreover, in the headandneck region,clinicians can easily detect tumour variations of thepatient volume and anatomy. In terms of planning time,...
... Advanced Head- and- Neck Cancer. International Journal of RadiationOncology*Biology*Physics 2009, 73:410-415.4. Cooper J, Fleming ID, editors, HD: HeadandNeck Cancer. AJCC Manualfor Staging of Cancer. ... 6:1http://www.ro-journal.com/content/6/1/1Page 3 of 8 25. Chao KSC, Gokhan O, Wade LT: Toxicity profile of intensity-modulatedradiation therapy for headandneck carcinoma and potential role of amifostine. Seminars in oncology ... observer-assessed instruments. Patient-reportedclinical swallowing function was evaluated using the“European Organi zation for Research and Tre atment of Cancer (EORTC) head- and- neck 35-item swallowingand...